MENS Jyong Biotech Ltd.

Fundamentals / CIK 0001954488 / USD

Jyong Biotech Ltd. reported $20.78M in total assets and a net loss of $4.67M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MENS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$4.37MFY 2023 Net Income: -$4.40M2023FY 2024 Net Income: -$3.02M2024FY 2025 Net Income: -$4.67M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $813K $927K $1.07M
Selling, General & Admin $1.79M $1.13M $1.73M
Total Operating Expenses $2.61M $2.06M $2.80M
Operating Income -$2.61M -$2.06M -$2.80M
EBITDA -$2.51M -$1.94M -$2.67M
Interest Income $610K $7.0K $56K
Interest Expense $2.54M $1.03M $757K
Income Before Tax -$4.67M -$3.02M -$4.40M
Net Income -$4.67M -$3.02M -$4.40M
Basic EPS -$0.06 -$0.04 -$0.06
Diluted EPS -$0.06 -$0.04 -$0.06
Basic Shares Outstanding 73.0M 71.6M 71.6M
Diluted Shares Outstanding 73.0M 71.6M 71.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for MENS.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $1.18M $98K
Cash & Short-Term Investments $1.18M $98K
Total Current Assets $15.54M $206K
Property, Plant & Equipment, Net $3.09M $3.05M
Other Non-Current Assets $6.0K $6.0K
Total Non-Current Assets $5.24M $6.16M
Total Assets $20.78M $6.37M
Accounts Payable $2.0K $3.0K
Short-Term Debt $15.34M --
Other Current Liabilities $3.45M $3.29M
Total Current Liabilities $34.81M $12.13M
Other Non-Current Liabilities $60K $58K
Total Non-Current Liabilities $10.87M $30.76M
Total Liabilities $45.68M $42.88M
Total Debt (incl. Leases) $15.44M $175K
Common Stock $1.0K $1.0K
Retained Earnings -$37.75M -$33.08M
Accumulated Other Comp. Income $682K $1.12M
Total Stockholders' Equity -$24.91M -$36.52M
Total Equity -$24.91M -$36.52M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31
Cash & Cash Equivalents $1.18M $98K
Cash & Short-Term Investments $1.18M $98K
Total Current Assets $15.54M $206K
Property, Plant & Equipment, Net $3.09M $3.05M
Other Non-Current Assets $6.0K $6.0K
Total Non-Current Assets $5.24M $6.16M
Total Assets $20.78M $6.37M
Accounts Payable $2.0K $3.0K
Short-Term Debt $15.34M --
Other Current Liabilities $3.45M $3.29M
Total Current Liabilities $34.81M $12.13M
Other Non-Current Liabilities $60K $58K
Total Non-Current Liabilities $10.87M $30.76M
Total Liabilities $45.68M $42.88M
Total Debt (incl. Leases) $15.44M $175K
Common Stock $1.0K $1.0K
Retained Earnings -$37.75M -$33.08M
Accumulated Other Comp. Income $682K $1.12M
Total Stockholders' Equity -$24.91M -$36.52M
Total Equity -$24.91M -$36.52M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$4.67M -$3.02M -$4.40M
Depreciation & Amortization $100K $120K $127K
Change in Payables -$1.0K $1.0K -$2.0K
Operating Cash Flow -$3.04M -$3.62M -$2.60M
Investing Cash Flow -$13.51M -- $95K
Common Stock Issued $17.77M -- --
Financing Cash Flow $17.63M $1.99M $2.03M
Net Change in Cash $1.08M -$1.64M -$532K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for MENS.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -22.5% -47.4% --
Current Ratio 0.45x 0.02x --
Quick Ratio 0.03x 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for MENS.
Source: SEC EDGAR CompanyFacts (CIK 0001954488) · from December 31, 2023 Data through December 31, 2025 · synced Nov 20, 2026, 05:47 UTC · Open in terminal